UncategorizedEnsysce Biosciences Stock Doubles In One Trading Session – Here’s Why Sumain Faisal2 months ago01 mins Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology. read more Post navigation Previous: Texas Instruments Q1 Earnings: Revenue Beat, EPS Beat, Strong Guidance — ‘Prepared To Navigate The Evolving Supply Chain Dynamics’Next: Here’s How Much You Would Have Made Owning OSI Systems Stock In The Last 15 Years Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Larry Ellison Overtakes Jeff Bezos, Mark Zuckerberg To Become World’s Second Richest Amid Oracle’s ‘Watershed’ Moment Sumain Faisal1 hour ago 0
Apple Reroutes 97% Of Foxconn iPhone Exports From India To US Between March And May As Trump Threatens 25% Tariff On Non-US-Made iPhones: Report Sumain Faisal1 hour ago 0
Trump Says ‘I Like Tesla’ As Feud With Elon Musk Subsides: ‘But I Also Like Combustion Engines’ Sumain Faisal1 hour ago 0